BackXLR Medical Overview
XLR Medical Corp.

XLR Medical Return on Equity

Valuation check: XLRM's ROE is 112.13%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

112.13%

Return on Equity

112.13%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

XLR Medical (XLRM) FAQ

The latest ROE for XLRM is 112.13%. That is above the sector sector average of 11.3%. Investors often review this figure alongside XLR Medical's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, XLRM currently prints 112.13% for ROE, while the sector average sits near 11.3%. That is roughly 892.6% above the sector mean. Large gaps often invite a closer look at XLR Medical's growth, margins, and balance sheet.

Return on Equity shows how effectively XLR Medical converts resources into returns. At 112.13%, XLRM may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting XLRM's ROE (112.13%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers